NMN Research Index
Browse 27 peer-reviewed NMN, NAD+, sirtuin, and longevity studies cited across the NMN Malaysia knowledge base. Plain-language summaries, PubMed links, and Malaysian buyer relevance.
-
β-Nicotinamide mononucleotide alleviates Alcohol-Induced liver injury in a mouse model through activation of NAD(+)/SIRT1 signaling pathways
Yang X, Zheng E, Lin Y, et al.
-
Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation
Yaku K, Palikhe S, Iqbal T, et al.
-
Widespread deployment of the human CD38 ADP-ribosyl cyclase fold in antibacterial and anti-eukaryotic polymorphic toxins
Martinkus J, Terradot L, Jurėnas D, et al.
-
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Yi L, Maier AB, Tao R, et al.
-
MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults
Pencina KM, Lavu S, Dos Santos M, et al.
-
Nicotinamide Riboside, a Promising Vitamin B(3) Derivative for Healthy Aging and Longevity: Current Research and Perspectives
Biţă A, Scorei IR, Ciocîlteu MV, et al.
-
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study
Lapatto HAK, Kuusela M, Heikkinen A, et al.
-
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
Igarashi M, Nakagawa-Nagahama Y, Miura M, et al.
-
Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study
Kim M, Seol J, Sato T, et al.
-
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
Okabe K, Yaku K, Uchida Y, et al.
-
Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol
Bai LB, Yau LF, Tong TT, et al.
-
Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women
Fukamizu Y, Uchida Y, Shigekawa A, et al.
-
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M, Yoshino J, Kayser BD, et al.
-
Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study
Liao B, Zhao Y, Wang D, et al.
-
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men
Irie J, Inagaki E, Fujita M, et al.
-
Slc12a8 is a nicotinamide mononucleotide transporter
Grozio A, Mills KF, Yoshino J, et al.
-
Safety and metabolism of long-term administration of NIAGEN (NR) in healthy overweight adults
Conze D, Brenner C, Kruger CL
-
NAD+ in brain aging and neurodegenerative disorders
Lautrup S, Sinclair DA, Mattson MP, et al.
-
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino J, Baur JA, Imai SI
-
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman L, Chwalek K, Sinclair DA
-
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Martens CR, Denman BA, Mazzo MR
-
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
Airhart SE, Shireman LM, Risler LJ, et al.
-
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
Mills KF, Yoshida S, Stein LR, et al.
-
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell SAJ, Schmidt MS, Weidemann BJ, et al.
-
NAD+ in aging, metabolism, and neurodegeneration
Verdin E
-
NAD+ and sirtuins in aging and disease
Imai SI, Guarente L
-
Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging
Gomes AP, Price NL, Ling AJ